Who is moving to which position
Resolved 25 May 2026Incoming appointee
1 itemDeparting officer
1 itemHigashi Taiyo (東 大陽) offered to retire from the company voluntarily to clarify management responsibility for the impairment loss on crypto-assets (Bitcoin) recognized by the company for the fiscal year ending March 2026. He is scheduled to retire upon the expiration of his term.
Will not remain on the Board of Directors
The company will transition to a new management structure to enhance corporate value over the medium to long term through the execution of its new medium-term management plan.
To support the expansion of the Group's healthcare platform business and the execution of its new medium-term management plan.
| Item | Details |
|---|---|
| Resolution date | 25 May 2026 |
| Scheduled Appointment Date | 27 June 2026 (after the conclusion of the 13th Annual General Meeting of Shareholders). This is subject to the approval and adoption of Proposal No. 1, Election of 5 Directors, at the 13th Annual General Meeting of Shareholders. |
| Date of departure | 27 June 2026 (at the conclusion of the 13th Annual General Meeting of Shareholders) |
| Name of appointee | Funakoshi Yusuke (舟越 勇介) |
| Appointee's new position | Directors |
| Appointee's previous position | Representative Director of 株式会社DataStrategy (incumbent) |
| Appointee's date of birth | 5 June 1985 |
| Number of shares held by the appointee | 3,200,000 shares (as of 25 May 2026, the date of the Board of Directors' resolution) |
| Name of departing officer | Higashi Taiyo (東 大陽) |
| Former position of departing officer | Directors |
| Reason for departure | Higashi Taiyo (東 大陽) offered to retire from the company voluntarily to clarify management responsibility for the impairment loss on crypto-assets (Bitcoin) recognized by the company for the fiscal year ending March 2026. He is scheduled to retire upon the expiration of his term. |
| Whether the incumbent will remain in office | Will not remain on the Board of Directors |
| Reason for change | The company will transition to a new management structure to enhance corporate value over the medium to long term through the execution of its new medium-term management plan. |
| Reasons for appointment | To support the expansion of the Group's healthcare platform business and the execution of its new medium-term management plan. |
| Number of directors after the change | 5 (number of outside directors: Not disclosed) |
| Subject to Approval by the General Meeting of Shareholders | Yes. This is subject to the approval and adoption of Proposal No. 1, Election of 5 Directors, at the 13th Annual General Meeting of Shareholders scheduled for 27 June 2026. |
Items this document does not state (5)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company will transition to a new management structure to enhance corporate value over the medium to long term through the execution of its new medium-term management plan. Higashi Taiyo (東 大陽) offered to retire voluntarily to clarify management responsibility for the impairment loss on crypto-assets (Bitcoin) recognized for the fiscal year ending March 2026. The new director candidate is being appointed to support the expansion of the healthcare platform business and the execution of the new medium-term management plan.